Channavix Therapeutics and Peregrine BioVentures are developing two patent families related to long-lasting, non-opioid, non-addictive pain therapeutics.
The UB researchers who have changed the way concussions are treated have been awarded a grant to conduct a clinical trial to take their Buffalo Concussion Protocol and apply it to the military environment.
UB researchers working alongside people with MS and their advocates have developed solutions that can open the door to better patient understanding about brain atrophy and potentially, better self-care.
When Brooke Lerner's life took an extremely unexpected turn earlier this year, (which she discusses in this video), it made sense that in reconfiguring her priorities, emergency medicine would still be one of them.
The NIDCR awarded two grants to UB, Roswell Park and Albert Einstein College of Medicine to explore how the oral microbiome interacts with opportunistic pathogens.